
Phentermine-Associated Atrial Fibrillation: Case Report and Literature Review
Author(s) -
Nouraldeen Manasrah,
Chandima J Herath,
Ali Al Sbihi,
Sarah Alqasem,
Andrew S. Kao,
Ahmed Jamal Chaudhary,
Rana Ismail
Publication year - 2022
Publication title -
european journal of case reports in internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2284-2594
DOI - 10.12890/2022_003267
Subject(s) - phentermine , medicine , atrial fibrillation , obesity , weight loss , cardiology , pediatrics , intensive care medicine
Obesity has become a major public health problem with increased prevalence. It is associated with cardiovascular mortality. Phentermine is approved for short-term obesity treatment in conjunction with lifestyle modifications. Palpitation is a well-documented side effect of phentermine. However atrial fibrillation (AF) is rarely reported. We present a case of new-onset AF in a healthy woman who was recently started on phentermine for weight loss.